The merger announcement is a significant positive catalyst for HUN shares, offering a premium and participation in substantial synergies. Traders should monitor the spread between HUN and OLN shares, as well as regulatory developments and shareholder vote timelines. The deal is expected to close in H1 2027, so near-term trading will focus on deal certainty and any competing offers.
Price Chart
Executive Summary
Huntsman and Olin announced a definitive all-stock merger of equals to create OlinHuntsman Corporation, a $12B+ North American chemicals leader. Huntsman shareholders will receive 0.5476 Olin shares per share, with Olin shareholders owning 54.5% and Huntsman shareholders 45.5% of the combined company. The deal is expected to generate over $400 million in cost synergies and close in the first half of 2027, subject to regulatory and shareholder approvals.
Key Financial Metrics
Key Facts
- All-stock merger of equals: Huntsman shareholders receive 0.5476 Olin shares per Huntsman share
- Post-merger ownership: Olin shareholders 54.5%, Huntsman shareholders 45.5%
- Combined 2025 revenue of approximately $12.5 billion
- Identified $400M+ in cost synergies and integration benefits ($300M+ within 3 years, $100M additional raw material benefits in 2031)
- Approximately $125M in cash tax benefits from accelerated net operating losses
- Expected closing in first half of 2027, subject to regulatory approvals and shareholder votes
- Ken Lane (Olin CEO) to be CEO of combined company; Peter Huntsman to be non-executive Chairman
- Headquarters to be in The Woodlands, Texas
- Transaction unanimously approved by both boards
Financial Impact
Transformative merger creating a $12B+ revenue chemicals leader with $400M+ annual synergies; Huntsman shareholders receive a premium via the exchange ratio based on 30-day VWAP
Risk Factors
- Regulatory approval risk, particularly antitrust review in the U.S. and other jurisdictions
- Shareholder approval required from both Olin and Huntsman shareholders
- Integration risk and ability to realize $400M+ synergies
- Cyclical chemicals industry could impact combined company's financial performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001104659-26-074267 |
| Document: tm2618028d3_425.htm | 0001104659-26-074267 |
| Document: tm2618028d3_ex99-2.htm | 0001104659-26-074267 |
| Document: 0001104659-26-074267-index-headers.html | 0001104659-26-074267 |
| Document: 0001104659-26-074267-index.html | 0001104659-26-074267 |
| Document: 0001104659-26-074267.txt | 0001104659-26-074267 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 25, 2026 5w ago | 8-K | $9.63 $8.86 | ▼ −8.00% | ▼ −9.20% | $8.53 (−11.42%) |
Aug 3, 2026 8w ago | Insider Buy | $10.02 $9.58 | ▼ −4.39% | ▼ −5.63% | $8.53 (−14.87%) |
Jul 31, 2026 8w ago | 425 | $10.02 $9.58 | ▼ −4.39% | ▼ −5.63% | $8.53 (−14.87%) |
Jul 31, 2026 8w ago | 425 | $10.02 $9.58 | ▼ −4.39% | ▼ −5.63% | $8.53 (−14.87%) |
Jul 14, 2026 11w ago | 425 | $11.91 $10.44 | ▼ −12.34% | ▼ −14.83% | $8.53 (−28.38%) |
Jul 13, 2026 11w ago | 425 | $11.61 $10.36 | ▼ −10.77% | ▼ −13.95% | $8.53 (−26.53%) |
Jul 13, 2026 11w ago | 425 | $11.61 $10.36 | ▼ −10.77% | ▼ −13.95% | $8.53 (−26.53%) |
Jun 25, 2026 14w ago | 425 | $11.41 $12.81 | ▲ +12.27% | ▲ +11.01% | $8.53 (−25.24%) |
Jun 17, 2026 15w ago | 425 | $12.73 $11.86 | ▼ −6.83% | ▼ −8.15% | $8.53 (−32.99%) |
Jun 16, 2026 15w ago | 425 | $12.73 $11.86 | ▼ −6.83% | ▼ −8.15% | $8.53 (−32.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access